» Articles » PMID: 1352943

PCNA Expression in Cutaneous Keratinous Neoplasms and Verruca Vulgaris

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1992 Jul 1
PMID 1352943
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Using an antibody to PCNA and a standard immunohistochemical system, the authors examined normal epidermis and cutaneous neoplasias for expression of PCNA, a protein associated with DNA polymerase delta and DNA replication. In squamous cell carcinoma in situ (SCCI), a unique expression of PCNA, which frequently involved the nuclei of all keratinocytes within the lesion, was found. Heaviest staining was in the uppermost layers of the epidermis. PCNA expression ended abruptly at the histologic margin of the lesion. Because SCCI can be associated with the presence of human papillomavirus (HPV) DNA, the authors evaluated PCNA expression in verruca vulgaris and found a pattern similar to that in SCCI. Assuming that PCNA expression in these two lesions is related to cell division, the authors hypothesize that the mechanisms that control proliferation in SCCI may be similar to those operative in verruca vulgaris.

Citing Articles

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Foote J, Ranger-Moore J, Einspahr J, Saboda K, Kenyon J, Warneke J Cancer Prev Res (Phila). 2009; 2(4):394-400.

PMID: 19336724 PMC: 4154592. DOI: 10.1158/1940-6207.CAPR-08-0210.


Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Bujia J, Sudhoff H, Holly A, Hildmann H, Kastenbauer E Eur Arch Otorhinolaryngol. 1996; 253(1-2):21-4.

PMID: 8932424 DOI: 10.1007/BF00176697.


E7 proteins of four groups of human papillomaviruses, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently.

Hiraiwa A, Kiyono T, Suzuki S, Ohashi M, Ishibashi M Virus Genes. 1996; 12(1):27-35.

PMID: 8879118 DOI: 10.1007/BF00369998.


PCNA immunostaining combined with AgNOR staining in esophageal squamous cell carcinoma to identify patients with a poor prognosis.

Morisaki Y, Shima S, Yoshizumi Y, Sugiura Y, Tanaka S, Tamai S Surg Today. 1995; 25(5):389-95.

PMID: 7640465 DOI: 10.1007/BF00311814.

References
1.
Miyachi K, Fritzler M, Tan E . Autoantibody to a nuclear antigen in proliferating cells. J Immunol. 1978; 121(6):2228-34. View

2.
Takahashi H, Strutton G, Parsons P . Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology. 1991; 18(3):221-7. DOI: 10.1111/j.1365-2559.1991.tb00829.x. View

3.
Hall P, Levison D, Woods A, Yu C, Kellock D, Watkins J . Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990; 162(4):285-94. DOI: 10.1002/path.1711620403. View

4.
Garcia R, Coltrera M, Gown A . Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol. 1989; 134(4):733-9. PMC: 1879787. View

5.
Celis J, Celis A . Individual nuclei in polykaryons can control cyclin distribution and DNA synthesis. EMBO J. 1985; 4(5):1187-92. PMC: 554322. DOI: 10.1002/j.1460-2075.1985.tb03758.x. View